Sitemap
- Contact
- Conditions
- Products & Services
-
Education
- ISICEM 2021: ABIOMED Symposia Prof. Susanna Price, Prof. Roberto Lorusso
- ABIOMED Digital Summit „Impella beyond the cathlab: open issues and clinical needs”- Recordings Part I+II
- EuroPCR 2021 digital – ABIOMED Symposia recordings
- Interview with Dr. Pappalardo on “Optimal ICU Management of patients requiring hemodynamic support with an Impella® device
- European Heart Journal Supplements: Impella beyond the cathlab: open issues and clinical needs
- IMP-IT Subgroup analysis on timinig of Impella and outcomes in cardiogenicshock or high-risk percutaneous coronary revascularization now published in: Catheter Cardiovasc Interv. 2021;1–13.
- JIM Congress 2021: ABIOMED Symposia Recording Dr. Jörn Tongers
- JIM Congress 2021: ABIOMED Symposia Recording Dr. Burzotta
- IMP-IT Subgroup analysis on revascularization extent (R-IMP IT) now published in JACC: Cardiovascular Interventions
- JESFC Congress 2021: ABIOMED Symposia Recording
- EUMS Congress 2020: ABIOMED Symposia Recording Prof. Jan Bélohlavek
- Interview Dr. Chieffo - Joint EAPCI /ACVC expert consensus document on percutaneous ventricular assist
- Digital Summit 2020- Cardiology: Recordings now on Demand
- Jeffrey Moses: Improved Outcomes with Contemporary Practices in PROTECT III
- Interview Dr. Mario Iannaccone: Short term outcomes of Impella® circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis
- Interview Dr. Mario Iannaccone: Comparison of ECMO vs ECpella in patients with non post-pericardiotomy cardiogenic shock: An updated meta-analysis
- Interview with Charles Simonton and PD Dr. Fadi Al-Rashid: STEMI DTU Rollout at the Heart and Vascular Center in Essen, Germany
- Interview with Charles Simonton and Prof. Dr. Norman Mangner: Protect IV Rollout in Dresden
- Interview Vas Panoulas and Mario Iannaccone: ECpella versus ECMO in Cardiogenic Shock: Two Independent Meta-analyses
- IABP for Acute-on-chronic Heart Failure Complicated by Cardiogenic Shock
- Data Integrity in Real-World Evidence
- STEMI-DTU and the Radical, Disruptive Concept of Delayed Reperfusion
- Building Collaboration Between Interventionalists and Cardiac Surgeons
- RESTORE EF Case Study: Contemporary Practices for Impella-supported Complete Revascularization
- RESTORE EF: Ejection Fraction Improvement with Complete Revascularization
- Case Study Epitomizing Results from RESTORE EF
- Heparin-Free Purge: Sodium Hydrogencarbonate-Based Purge Solution
- FAQ: Anticoagulation
- REVIVED-BCIS2 Interview: Gregg Stone and Divaka Perera
- CAMP at TCT 2022: Data Integrity in Real-World Evidence
- Live from TCT – September 17, 2022
- Live from TCT – September 19, 2022
- Live from TCT – September 18, 2022
- Dr. Junya Ako: AMICS Outcomes from J-PVAD Study - TCT 2022
- Dr. Jonathan Hill: Influential Trials in High-risk PCI at TCT 2022
- TCT 2022: Influential Trials in High-Risk PCI
- TCT 2022: OPTIMUM Study Sub-Analysis Results
- Dr. Navin Kapur: Lessons Learned in STEMI DTU™ Pilot Study–TCT 2022
- Dr. Katherine Kunkel: Best Practices in Cardiogenic Shock–TCT 2022
- Dr. Navin Kapur: Cardiogenic Shock Working Group and SCAI Shock Stages–TCT 2022
- Dr. Kate Kearney: Contemporary Techniques for Optimal Outcomes in High-risk PCI–TCT 2022
- Dr. Junya Ako: J-PVAD Registry and Data Presented at TCT 2022
- Christophe Vandenbriele: Anticoagulation Challenges in Patiens Supported with Impella® Heart Pumps
- EACTS 2022 Recordings
- Heparin-free Purge Help Manage Anticoagulation in Patients supported with Impella Heart Pumps
- Clinical Trial Update with Chuck Simonton, MD
- Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice
- Burzotta: Status Quo and Outlook for pMCS Strategies
- Best Practices for Optimizing Impella Use in High-Risk Patients
- European Best Practice: A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention to Improve Outcome After High-Risk Coronary Interventions
- Optimized Patient Selection in High-Risk Protected Percutaneous Coronary Intervention
- Standardized Pre-Procedural Clinical Workup for Protected Percutaneous Coronary Intervention
- What Is Known in Pre-, Peri-, and Post-Procedural Anticoagulation in Micro-Axial Flow Pump Protected Percutaneous Coronary Intervention?
- Defining the Optimal Revascularization Strategy During Protected High-Risk Procedures With Impella Heart Pumps
- Handling High-Risk Patients in the Catheterization Laboratory
- Optimal Bail-out and Complication Management Strategies in Protected High-Risk Percutaneous Coronary Intervention With the Impella Heart Pump
- Specific Clinical Vignettes in High-Risk Protected Percutaneous Coronary Intervention
- ECMO-CS Trial: VA ECMO in Rapidly Deteriorating or Severe Cardiogenic Shock
- ELSO 2022 Q&A with Evgenij Potapov, Roberto Lorusso, and Alan Gass
- 85% Survival with Impella 5.5® with SmartAssist® Heart Pump ECpella
- Prof. Evgenij Potapov : SOPs for Cardiogenic Shock
- The ECpella 2+ Concept
- How to Achieve Better Outcomes in PCCS
- ECpella in Refractory Cardiac Arrest
- Improving Survival in Cardiogenic Shock — A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support
- Interview Dr. Benedikt Schrage: Early Left Ventricular Unloading Improves Survival in Patients With Cardiogenic Shock Undergoing Extracorporeal Membrane Oxygenation (ECMO)
- A “Treasure Trove” of Complete Revascularization Data
- Vandenbriele Letter: “We Need More Pieces of the Puzzle”
- Vandenbriele: Anticoagulation and Protected PCI
- Karim Ibrahim: Handling High-risk Patients in the Cath Lab
- Renal Protection and Hemodynamic Improvement by Impella® Heart Pumps
- Optimal Revascularization Strategies During Protected PCI
- Optimized Patient Selection for High-risk Protected PCI
- Pre-Procedural Clinical Workup for Protected PCI
- EuroPCR 2023: How to Optimize High-risk PCI Patient Outcome: Opening and Session Objectives
- EuroPCR 2023: Complete Revascularization with pVAD vs IABP
- EuroPCR 2023: How to Optimize High-risk PCI Patient Outcome: Discussion & Audience Interaction
- EuroPCR 2023: Best Practice Approach to High-risk PCI
- Acute Coronary Syndromes and High-Risk PCI: State of the Art (York Part II)
- York Data Analysis: York I vs York II - A Comparison
- Revascularization Completeness with pVAD vs IABP (York Part I)
- ESC 2023: Predictors of 90-day Outcomes from York Analysis
- EuroPCR 2023: Timing of Active LV Unloading in Patients on VA ECMO
-
Education Library
- ISICEM 2021: ABIOMED Symposia Prof. Susanna Price, Prof. Roberto Lorusso
- ABIOMED Digital Summit „Impella beyond the cathlab: open issues and clinical needs”- Recordings Part I+II
- EuroPCR 2021 digital – ABIOMED Symposia recordings
- Interview with Dr. Pappalardo on “Optimal ICU Management of patients requiring hemodynamic support with an Impella® device
- European Heart Journal Supplements: Impella beyond the cathlab: open issues and clinical needs
- IMP-IT Subgroup analysis on timinig of Impella and outcomes in cardiogenicshock or high-risk percutaneous coronary revascularization now published in: Catheter Cardiovasc Interv. 2021;1–13.
- JIM Congress 2021: ABIOMED Symposia Recording Dr. Jörn Tongers
- JIM Congress 2021: ABIOMED Symposia Recording Dr. Burzotta
- IMP-IT Subgroup analysis on revascularization extent (R-IMP IT) now published in JACC: Cardiovascular Interventions
- JESFC Congress 2021: ABIOMED Symposia Recording
- EUMS Congress 2020: ABIOMED Symposia Recording Prof. Jan Bélohlavek
- Interview Dr. Chieffo - Joint EAPCI /ACVC expert consensus document on percutaneous ventricular assist
- Digital Summit 2020- Cardiology: Recordings now on Demand
- Jeffrey Moses: Improved Outcomes with Contemporary Practices in PROTECT III
- Interview Dr. Mario Iannaccone: Short term outcomes of Impella® circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis
- Interview Dr. Mario Iannaccone: Comparison of ECMO vs ECpella in patients with non post-pericardiotomy cardiogenic shock: An updated meta-analysis
- Interview with Charles Simonton and PD Dr. Fadi Al-Rashid: STEMI DTU Rollout at the Heart and Vascular Center in Essen, Germany
- Interview with Charles Simonton and Prof. Dr. Norman Mangner: Protect IV Rollout in Dresden
- Interview Vas Panoulas and Mario Iannaccone: ECpella versus ECMO in Cardiogenic Shock: Two Independent Meta-analyses
- IABP for Acute-on-chronic Heart Failure Complicated by Cardiogenic Shock
- Data Integrity in Real-World Evidence
- STEMI-DTU and the Radical, Disruptive Concept of Delayed Reperfusion
- Building Collaboration Between Interventionalists and Cardiac Surgeons
- RESTORE EF Case Study: Contemporary Practices for Impella-supported Complete Revascularization
- RESTORE EF: Ejection Fraction Improvement with Complete Revascularization
- Case Study Epitomizing Results from RESTORE EF
- Heparin-Free Purge: Sodium Hydrogencarbonate-Based Purge Solution
- FAQ: Anticoagulation
- REVIVED-BCIS2 Interview: Gregg Stone and Divaka Perera
- CAMP at TCT 2022: Data Integrity in Real-World Evidence
- Live from TCT – September 17, 2022
- Live from TCT – September 19, 2022
- Live from TCT – September 18, 2022
- Dr. Junya Ako: AMICS Outcomes from J-PVAD Study - TCT 2022
- Dr. Jonathan Hill: Influential Trials in High-risk PCI at TCT 2022
- TCT 2022: Influential Trials in High-Risk PCI
- TCT 2022: OPTIMUM Study Sub-Analysis Results
- Dr. Navin Kapur: Lessons Learned in STEMI DTU™ Pilot Study–TCT 2022
- Dr. Katherine Kunkel: Best Practices in Cardiogenic Shock–TCT 2022
- Dr. Navin Kapur: Cardiogenic Shock Working Group and SCAI Shock Stages–TCT 2022
- Dr. Kate Kearney: Contemporary Techniques for Optimal Outcomes in High-risk PCI–TCT 2022
- Dr. Junya Ako: J-PVAD Registry and Data Presented at TCT 2022
- Christophe Vandenbriele: Anticoagulation Challenges in Patiens Supported with Impella® Heart Pumps
- EACTS 2022 Recordings
- Heparin-free Purge Help Manage Anticoagulation in Patients supported with Impella Heart Pumps
- Clinical Trial Update with Chuck Simonton, MD
- Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice
- Burzotta: Status Quo and Outlook for pMCS Strategies
- Best Practices for Optimizing Impella Use in High-Risk Patients
- European Best Practice: A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention to Improve Outcome After High-Risk Coronary Interventions
- Optimized Patient Selection in High-Risk Protected Percutaneous Coronary Intervention
- Standardized Pre-Procedural Clinical Workup for Protected Percutaneous Coronary Intervention
- What Is Known in Pre-, Peri-, and Post-Procedural Anticoagulation in Micro-Axial Flow Pump Protected Percutaneous Coronary Intervention?
- Defining the Optimal Revascularization Strategy During Protected High-Risk Procedures With Impella Heart Pumps
- Handling High-Risk Patients in the Catheterization Laboratory
- Optimal Bail-out and Complication Management Strategies in Protected High-Risk Percutaneous Coronary Intervention With the Impella Heart Pump
- Specific Clinical Vignettes in High-Risk Protected Percutaneous Coronary Intervention
- ECMO-CS Trial: VA ECMO in Rapidly Deteriorating or Severe Cardiogenic Shock
- ELSO 2022 Q&A with Evgenij Potapov, Roberto Lorusso, and Alan Gass
- 85% Survival with Impella 5.5® with SmartAssist® Heart Pump ECpella
- Prof. Evgenij Potapov : SOPs for Cardiogenic Shock
- The ECpella 2+ Concept
- How to Achieve Better Outcomes in PCCS
- ECpella in Refractory Cardiac Arrest
- Improving Survival in Cardiogenic Shock — A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support
- Interview Dr. Benedikt Schrage: Early Left Ventricular Unloading Improves Survival in Patients With Cardiogenic Shock Undergoing Extracorporeal Membrane Oxygenation (ECMO)
- A “Treasure Trove” of Complete Revascularization Data
- Vandenbriele Letter: “We Need More Pieces of the Puzzle”
- Vandenbriele: Anticoagulation and Protected PCI
- Karim Ibrahim: Handling High-risk Patients in the Cath Lab
- Renal Protection and Hemodynamic Improvement by Impella® Heart Pumps
- Optimal Revascularization Strategies During Protected PCI
- Optimized Patient Selection for High-risk Protected PCI
- Pre-Procedural Clinical Workup for Protected PCI
- EuroPCR 2023: How to Optimize High-risk PCI Patient Outcome: Opening and Session Objectives
- EuroPCR 2023: Complete Revascularization with pVAD vs IABP
- EuroPCR 2023: How to Optimize High-risk PCI Patient Outcome: Discussion & Audience Interaction
- EuroPCR 2023: Best Practice Approach to High-risk PCI
- Acute Coronary Syndromes and High-Risk PCI: State of the Art (York Part II)
- York Data Analysis: York I vs York II - A Comparison
- Revascularization Completeness with pVAD vs IABP (York Part I)
- ESC 2023: Predictors of 90-day Outcomes from York Analysis
- EuroPCR 2023: Timing of Active LV Unloading in Patients on VA ECMO
- Online Education on Demand
- Education Programs
- Upcoming Events
- CAMP
-
Resources
-
Downloads
- Resources/Downloads/Impella CP® with SmartAssist® Brochure
- Resources/Downloads/Impella CP® with SmartAssist® Data Sheet
- Resources/Downloads/Step-by-Step Guide: Impella CP® with SmartAssist®
- Resources/Downloads/Impella 5.5® with SmartAssist® Brochure
- Resources/Downloads/Step by Step Guide: Impella 5.5® with SmartAssist®
- Resources/Downloads/Impella 5.0 Brochure
- Resources/Downloads/Step by Step Guide: Impella 5.0®
- Ressources/Downloads/Impella RP® Brochure
-
Downloads
- Privacy Policy
- Terms of Use
- Safety Information
- Sitemap
- Cookie Settings